🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

CDNA CDNA R2K

$22.82
+34.31% 1Y

Market & Price

Market Cap
-
Current Price
$22.82
High / Low (52W)
$22.82 / $11.57
Beta
-

Valuation

Stock P/E
-
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
-

Profitability & Returns

ROCE
-7.75%
ROE
-
ROA
-
Profit Margin
-
Op Margin
-
EPS (Latest Qtr)
$0.05
EPS (TTM)
$-

Balance Sheet & Liquidity

Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
$413.23M
Current Assets
$257.13M
Working Capital
$167.28M

Ownership

Promoter Holding
-
Chg in Prom Hold
-
FII / Inst Holding
-
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
-
EBITDA
-
Free Cash Flow
-
Operating Cash Flow
-
Shares Outstanding
-
Gross Margin
-
Payout Ratio
-

Growth (CAGR)

Revenue 5Y
5.68%
Profit 5Y
24.04%
Revenue (YoY)
-
Earnings (YoY)
-

PROS

  • Profit CAGR of 24.0% over 5 years.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

⚙Ad space

Quarterly Results

Figures in USD.

Metric Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue -------11.58M12.05M12.19M12.50M14.05M17.82M21.18M23.51M25.98M31.45M33.81M35.82M38.38M41.80M53.37M67.40M74.19M75.59M79.42M80.63M79.36M77.26M70.30M67.19M72.05M92.27M--84.69M86.68M100.06M108.39M117.70M
Cost of Revenue -----------------------------------28.41M28.66M30.65M35.51M33.63M
Gross Profit ------------10.62M12.30M-16.25M19.94M22.32M-25.99M26.78M--------------56.27M58.02M69.40M72.87M84.07M
Operating Expenses -----------------------------------64.28M68.79M69.65M78.91M82.27M
Operating Income -2.89M-3.19M--6.57M-6.97M-4.93M--8.54M-3.60M-3.86M--5.24M-5.21M-2.72M--5.40M-6.84M-6.75M--5.75M-10.80M-2.91M-858.00K-4.74M-8.73M-19.05M-21.72M-17.34M-24.32M-27.62M-28.78M-22.57M-7.33M---8.01M-10.77M-246.00K-6.04M1.80M
EBITDA ------------------------------------3.07M-5.72M4.92M-780.00K7.12M
Interest Expense ----------------------------------------
Pretax Income ------------------------------------10.29M-8.69M1.66M-3.76M2.78M
Tax Provision -----------------------------------58.00K-117.00K-15.00K345.00K-32.00K
Net Income -3.19M-3.49M-4.76M-9.75M-10.47M-3.76M-15.48M-5.56M-3.97M-14.27M-31.67M-8.97M-14.06M-19.97M-3.75M-7.53M-7.85M-1.81M-4.78M-5.82M-6.56M-2.82M-687.00K-1.93M-11.90M-19.65M-21.70M-16.94M-23.75M-24.95M-23.48M-19.89M-4.62M---10.35M-8.57M1.68M-4.11M2.81M
Diluted EPS -0.27-0.29-0.40-0.81-0.77-0.26-0.73-0.26-0.19-0.63-1.13-0.30-0.40-0.54-0.09-0.18-0.19-0.04-0.11-0.14-0.15-0.06-0.01-0.04-0.23-0.37-0.41-0.32-0.44-0.46-0.43-0.38-0.09---0.19-0.160.03-0.080.05
R&D Expense 2.51M2.70M-3.16M3.14M2.93M-3.28M3.12M2.96M-3.37M3.50M3.87M-5.61M7.63M8.52M-10.01M13.13M12.47M16.00M19.04M19.44M21.88M22.63M22.31M24.36M20.23M19.00M18.71M19.69M17.49M-18.52M16.83M16.77M-21.42M

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue ----40.63M48.32M76.57M127.07M192.19M-321.79M280.32M333.79M379.81M
Cost of Revenue ----------112.21M102.07M109.70M123.24M
Gross Profit -----26.95M43.58M81.61M--209.58M178.26M224.09M256.57M
Operating Expenses ----------286.81M285.32M279.62M281.64M
Operating Income -2.34M-857.00K1.25M-11.93M-37.33M-20.29M-15.58M-24.53M-22.53M--77.23M-107.06M-55.53M-25.07M
EBITDA -----------61.22M-87.24M-35.78M-4.66M
Interest Expense --------------
Pretax Income -----------76.23M-190.14M52.86M-21.08M
Tax Provision ----------379.00K141.00K310.00K271.00K
Net Income -5.06M-3.54M781.00K-13.71M-39.47M-55.47M-46.76M-21.97M-18.71M--76.61M-190.28M52.55M-21.35M
Diluted EPS -5.01-3.500.10-1.16-2.39-2.38-1.31-0.52-0.40--1.44-3.540.93-0.40
R&D Expense 4.75M3.18M3.85M9.33M12.38M12.39M14.51M30.71M48.94M76.53M90.39M82.42M72.51M71.43M

Compounded Sales Growth

5 Years:5.68%
1 Year:-

Compounded Profit Growth

5 Years:24.04%
1 Year:-

Stock Price Performance

1 Year:+34.31%
6 Months:+27.49%
3 Months:+21.64%
1 Month:+9.71%

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2011Dec 2012Dec 2013Dec 2014Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --9.87M61.14M63.28M61.37M59.34M55.64M48.83M100.45M102.09M76.73M80.32M77.74M75.09M83.56M130.70M151.74M368.51M-542.99M466.83M491.05M413.23M
Current Assets --------------------387.85M313.71M351.83M257.13M
Cash & Equivalents 2.36M5.83M5.13M36.43M---29.89M---17.26M---16.89M64.62M38.22M134.67M-89.92M82.20M114.69M65.43M
Inventory --------------------19.23M19.47M19.50M26.70M
Receivables --------------------66.31M51.06M64.61M42.63M
Total Liabilities --25.34M19.84M---26.14M---56.97M---89.52M34.77M52.74M90.83M-112.08M205.50M112.62M110.13M
Current Liabilities --7.59M11.13M---10.15M---40.83M---42.91M19.50M34.83M69.22M-75.97M78.07M89.37M89.85M
Long Term Debt --10.91M5.45M14.61M13.39M12.12M12.89M11.37M10.07M8.50M1.10M0021.17M18.34M000-----
Total Debt --------------------39.00M34.22M28.37M26.19M
Total Equity -142.22M-147.20M-150.67M41.30M---29.49M---19.48M----6.13M95.93M99.00M277.68M-430.91M261.33M378.43M303.10M
Shares Outstanding --------------------53.53M51.50M54.77M50.92M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow -----16.52M-14.31M-4.01M-2.77M33.43M--25.24M-18.39M38.05M42.03M
Investing Cash Flow -----21.12M-6.11M-7.93M-22.58M-100.39M--228.50M40.45M-483.00K2.16M
Financing Cash Flow ----24.93M29.38M50.27M-132.00K163.15M--4.54M-29.61M-5.61M-93.39M
Capital Expenditure -141.00K-98.00K-733.00K-1.20M-549.00K-186.00K-2.04M----24.33M-9.24M-6.48M-6.59M
Free Cash Flow -----17.07M-14.49M-6.04M----49.57M-27.63M31.56M35.44M
Net Change in Cash -----------258.28M-7.55M31.96M-49.20M
Share Buybacks --------00642.00K27.54M522.00K87.77M

Ratios (Annual)

Figures in %.

Metric Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % -----55.8%56.9%64.2%--65.1%63.6%67.1%67.6%
Operating Margin % -----91.9%-42.0%-20.3%-19.3%-11.7%--24.0%-38.2%-16.6%-6.6%
Net Margin % -----97.1%-114.8%-61.1%-17.3%-9.7%--23.8%-67.9%15.7%-5.6%
ROE % 3.4%2.4%1.9%-46.5%-202.6%904.3%-48.7%-22.2%-6.7%--17.8%-72.8%13.9%-7.0%
ROCE % --37.6%2.5%-26.2%-104.0%-49.9%-14.0%-21.0%-7.5%--16.5%-27.5%-13.8%-7.8%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for CDNA

No recent headlines available.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space